264 related articles for article (PubMed ID: 8208308)
1. Comparison of the in vitro binding characteristics of the beta-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla.
May T; Greube A; Strauss S; Heineke D; Lehmann J; Rommelspacher H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):308-17. PubMed ID: 8208308
[TBL] [Abstract][Full Text] [Related]
2. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
3. Harman (1-methyl-beta-carboline) is a natural inhibitor of monoamine oxidase type A in rats.
Rommelspacher H; May T; Salewski B
Eur J Pharmacol; 1994 Jan; 252(1):51-9. PubMed ID: 8149995
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of a distinct class of high-affinity binding sites for [3H]norharman [( 3H]beta-carboline) in the rat brain.
Pawlik M; Rommelspacher H
Eur J Pharmacol; 1988 Mar; 147(2):163-71. PubMed ID: 3366173
[TBL] [Abstract][Full Text] [Related]
5. [3H]harman binding experiments. II: Regional and subcellular distribution of specific [3H]harman binding and monoamine oxidase subtypes A and B activity in marmoset and rat.
May T; Pawlik M; Rommelspacher H
J Neurochem; 1991 Feb; 56(2):500-8. PubMed ID: 1988553
[TBL] [Abstract][Full Text] [Related]
6. 1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
May T
Neurosci Lett; 1993 Nov; 162(1-2):55-8. PubMed ID: 8121637
[TBL] [Abstract][Full Text] [Related]
7. [3H]harman binding experiments. I: A reversible and selective radioligand for monoamine oxidase subtype A in the CNS of the rat.
May T; Rommelspacher H; Pawlik M
J Neurochem; 1991 Feb; 56(2):490-9. PubMed ID: 1988552
[TBL] [Abstract][Full Text] [Related]
8. [3H]norharman ([3H]beta-carboline) binds reversibly and with high affinity to a specific binding site in rat liver.
Greube A; Rommelspacher H
Neurochem Res; 1993 Sep; 18(9):1029-31. PubMed ID: 8232719
[TBL] [Abstract][Full Text] [Related]
9. The high-affinity binding of [3H]norharman ([3H]beta-carboline) to the ethanol-inducible cytochrome P450 2E1 in rat liver.
Stawowy P; Bonnet R; Rommelspacher H
Biochem Pharmacol; 1999 Mar; 57(5):511-20. PubMed ID: 9952314
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
[TBL] [Abstract][Full Text] [Related]
11. Human monoamine oxidase enzyme inhibition by coffee and beta-carbolines norharman and harman isolated from coffee.
Herraiz T; Chaparro C
Life Sci; 2006 Jan; 78(8):795-802. PubMed ID: 16139309
[TBL] [Abstract][Full Text] [Related]
12. Quantitative autoradiography of [3H]norharman [( 3H]beta-carboline) binding sites in the rat brain.
Pawlik M; Kaulen P; Baumgarten HG; Rommelspacher H
J Chem Neuroanat; 1990; 3(1):19-24. PubMed ID: 2156525
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
14. Identification of imidazoline-receptor binding sites in cortex and medulla of the bovine adrenal gland. Colocalization with MAO-A and MAO-B.
King PR; Gundlach AL; Louis WJ
Ann N Y Acad Sci; 1999 Jun; 881():161-70. PubMed ID: 10415911
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
Herraiz T
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibitory activity in tobacco particulate matter: Are harman and norharman the only physiologically relevant inhibitors?
Truman P; Grounds P; Brennan KA
Neurotoxicology; 2017 Mar; 59():22-26. PubMed ID: 28057462
[TBL] [Abstract][Full Text] [Related]
17. Specific binding of [(18)F]fluoroethyl-harmol to monoamine oxidase A in rat brain cryostat sections, and compartmental analysis of binding in living brain.
Maschauer S; Haller A; Riss PJ; Kuwert T; Prante O; Cumming P
J Neurochem; 2015 Dec; 135(5):908-17. PubMed ID: 26386360
[TBL] [Abstract][Full Text] [Related]
18. [Effects of harman and norharman on aflatoxin B1 and aminopyrine metabolism by phenobarbital and 3-methylcholanthrene-induced rat liver microsomes].
Lin DX
Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Jul; 26(4):209-12. PubMed ID: 1302193
[TBL] [Abstract][Full Text] [Related]
19. [3H]Harman labels selectively and with high affinity the active site of monoamine oxidase (EC 1.4.3.4) subtype A (MAO-A) in rat, marmoset, and pig.
May T; Strauss S; Rommelspacher H
J Neural Transm Suppl; 1990; 32():93-102. PubMed ID: 2128516
[TBL] [Abstract][Full Text] [Related]
20. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
